A PHASE I STUDY OF AT-101 PLUS RADIOTHERAPY AND TEMOZOLOMIDE AND AT-101 PLUS ADJUVANT TEMOZOLOMIDE FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME

被引：0
|
作者：
Fiveash, John
Nabors, Louis B.
Mikkelsen, Tom
Peereboom, David M.
Lesser, Glenn J.
Chowdhary, Sajeel A.
Grossman, Stuart
Ye, Xiaubu
Leopold, Lance
Rosenfeld, Myrna
机构：
来源：
NEURO-ONCOLOGY | 2009年 / 11卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：666 / 666
页数：1
相关论文
共 50 条
  • [21] Extended adjuvant temozolomide for treatment of newly diagnosed glioblastoma multiforme
    Gloria B. Roldán Urgoiti
    Amitabh D. Singh
    Jacob C. Easaw
    Journal of Neuro-Oncology, 2012, 108 : 173 - 177
  • [22] Enzastaurin plus temozolomide with radiation therapy in glioblastoma multiforme: A phase I study
    Butowski, Nicholas
    Chang, Susan M.
    Lamborn, Kathleen R.
    Polley, Mei Yin
    Parvataneni, R.
    Hristova-Kazmierski, Maria
    Musib, Luna
    Nicol, Steven J.
    Thornton, Donald E.
    Prados, Michael D.
    NEURO-ONCOLOGY, 2010, 12 (06) : 608 - 613
  • [23] Temozolomide and Radiotherapy for Newly Diagnosed Glioblastoma Multiforme: A Systematic Review
    Yang, Li-Juan
    Zhou, Chang-Fu
    Lin, Zhi-Xiong
    CANCER INVESTIGATION, 2014, 32 (02) : 31 - 36
  • [24] Phase I/II study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme (GBM) or gliosarcoma
    Butowski, N. A.
    Lamborn, K.
    Chang, S.
    Thornton, D.
    DeBoer, R.
    Page, M.
    Rabbitt, J.
    Parvanateni, R.
    Kivett, V.
    Nicol, S.
    Prados, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [25] PHASE II TRIAL OF SURVAXM PLUS TEMOZOLOMIDE FOR NEWLY DIAGNOSED GLIOBLASTOMA
    Ahluwalia, Manmeet
    Ciesielski, Michael J.
    Reardon, David A.
    Abad, Ajay
    Curry, William
    Wong, Eric
    Peereboom, David
    Figel, Sheila
    Hutson, Alan
    Groman, Adrienne
    Withers, Henry
    Liu, Song
    Belal, Ahmed
    Qiu, Jingxin
    Mogensen, Kathleen
    Schilero, Cathy
    Khosla, Atulya
    Casucci, Danielle
    Mechtler, Laszlo
    Fenstermaker, Robert
    NEURO-ONCOLOGY, 2022, 24 : 66 - 66
  • [26] Phase II Study of Erlotinib Plus Temozolomide During and After Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
    Prados, Michael D.
    Chang, Susan M.
    Butowski, Nicholas
    DeBoer, Rebecca
    Parvataneni, Rupa
    Carliner, Hannah
    Kabuubi, Paul
    Ayers-Ringler, Jennifer
    Rabbitt, Jane
    Page, Margaretta
    Fedoroff, Anne
    Sneed, Penny K.
    Berger, Mitchel S.
    McDermott, Michael W.
    Parsa, Andrew T.
    Vandenberg, Scott
    James, C. David
    Lamborn, Kathleen R.
    Stokoe, David
    Haas-Kogan, Daphne A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (04) : 579 - 584
  • [27] Radiotherapy plus concomitant and adjuvant temozolomide for newly diagnosed glioblastoma (vol 352, pg 19, 2005)
    Stupp, R
    Mason, WP
    van den Beuf, MJ
    ANNALS OF ONCOLOGY, 2005, 16 (06) : 949 - 949
  • [28] Randomized phase II study of temozolomide and radiotherapy compared with radiotherapy alone in newly diagnosed glioblastoma multiforme
    Athanassiou, H
    Synodinou, M
    Maragoudakis, E
    Paraskevaidis, M
    Verigos, C
    Misailidou, D
    Antonadou, D
    Saris, G
    Beroukas, K
    Karageorgis, P
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (10) : 2372 - 2377
  • [29] A retrospective study of the safety of BCNU wafers with concurrent temozolomide and radiotherapy and adjuvant temozolomide for newly diagnosed glioblastoma patients
    Pan, Edward
    Mitchell, Susan B.
    Tsai, Jerry S.
    JOURNAL OF NEURO-ONCOLOGY, 2008, 88 (03) : 353 - 357
  • [30] A retrospective study of the safety of BCNU wafers with concurrent temozolomide and radiotherapy and adjuvant temozolomide for newly diagnosed glioblastoma patients
    Edward Pan
    Susan B. Mitchell
    Jerry S. Tsai
    Journal of Neuro-Oncology, 2008, 88 : 353 - 357
12345